Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Compounded tirzepatide has a similar active ingredient as the FDA-approved brands
Marketing language emphasizing purity without proof suggests overcompensation for inferior products
f , SDS-PAGE immunoblot of complex I and II subunits in isolated gWAT mitochondria from Control and NDI1 mice after 10 weeks of HFD feeding (n = 6)
Studied use areas Body-weight reduction under clinical-trial investigation Glycaemic-control research Appetite and satiety signalling Energy-expenditure and fat-oxidation endpoints Safety & status Investigational agent that is not yet approved
US$ 26.91
US$ 22.93
US$ 20.13
US$ 27.98
US$ 28.55
